Pfizer-BioNTech’s Updated COVID-19 Vaccine Gets FDA Nod for 2026-2027
Pfizer Inc. and BioNTech SE said Thursday that U.S. regulators have cleared their refreshed COVID-19 shot, giving American providers a strain-matched option just as the fall...
Maharashtra FDA Seizes ₹11.19 Lakh Reactin Plus Stock from Cipla Facility
The Maharashtra Food and Drug Administration (FDA) has cancelled the drug sale licence of Cipla Pharma & Life Sciences Ltd's Carrying and Forwarding (C&F)...
Department of Pharmaceuticals Reopens ₹5,000 Crore Pharma Innovation Scheme for Second Round of Applications
India's Department of Pharmaceuticals has opened a fresh application window for its flagship Promotion of Research and Innovation in Pharma & MedTech (PRIP) initiative, offering startups, MSMEs,...
Bioforum the Data Masters Expands Global Footprint with New Office and GCC in Bengaluru, India
Bioforum the Data Masters, a leading global biometric Contract Research Organization (CRO), announced the opening of its new office and Global Capability Center (GCC) in Bengaluru. The...
40,468 Lives Screened: Alembic Pharmaceuticals Earns Asia Book of Records Recognition
Alembic Pharmaceuticals Limited has been recognized by the Asia Book of Records for conducting one of the largest blood pressure screening initiatives in the...
Cipla’s Pithampur Facility Receives 7 FDA Observations Following Inspection
Cipla Limited announced the conclusion of a routine Current Good Manufacturing Practice (cGMP) inspection conducted by the United States Food and Drug Administration (US FDA)...
